NEW YORK, March 09, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning,
Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Envision Healthcare
Corporation (NYSE:EVHC), Taylor Morrison Home Corporation (NYSE:TMHC), Vertex Pharmaceuticals Incorporated
(NASDAQ:VRTX), ReShape Lifesciences Inc. (NASDAQ:RSLS), American Axle & Manufacturing Holdings, Inc. (NYSE:AXL), and Lattice
Semiconductor Corporation (NASDAQ:LSCC), including updated fundamental summaries, consolidated fiscal reporting, and
fully-qualified certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available to readers at the links below.
EVHC DOWNLOAD: http://Fundamental-Markets.com/register/?so=EVHC
TMHC DOWNLOAD: http://Fundamental-Markets.com/register/?so=TMHC
VRTX DOWNLOAD: http://Fundamental-Markets.com/register/?so=VRTX
RSLS DOWNLOAD: http://Fundamental-Markets.com/register/?so=RSLS
AXL DOWNLOAD: http://Fundamental-Markets.com/register/?so=AXL
LSCC DOWNLOAD: http://Fundamental-Markets.com/register/?so=LSCC
(You may have to copy and paste the link into your browser and hit the [ENTER] key)
The new research reports from Fundamental Markets, available for free download at the links above, examine
Envision Healthcare Corporation (NYSE:EVHC), Taylor Morrison Home Corporation (NYSE:TMHC), Vertex Pharmaceuticals Incorporated
(NASDAQ:VRTX), ReShape Lifesciences Inc. (NASDAQ:RSLS), American Axle & Manufacturing Holdings, Inc. (NYSE:AXL), and Lattice
Semiconductor Corporation (NASDAQ:LSCC) on a fundamental level and outlines the overall demand for their products and services in
addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several
excerpts from the recently released reports are available to today's readers below.
-----------------------------------------
Important Notice: the following excerpts are not designed to be standalone
summaries and as such, important information may be missing from these samples. Please download the entire research report, free of
charge, to ensure you are reading all relevant material information. All information in this release was accessed March 6th, 2018.
Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.
-----------------------------------------
ENVISION HEALTHCARE CORPORATION (EVHC) REPORT OVERVIEW
Envision Healthcare's Recent Financial Performance
For the three months ended December 31st, 2017 vs December 31st, 2016, Envision Healthcare reported revenue of
$2,003.00MM vs $1,192.50MM (up 67.97%) and basic earnings per share $1.18 vs -$2.52. For the twelve months ended December 31st,
2017 vs December 31st, 2016, Envision Healthcare reported revenue of $7,819.30MM vs $3,497.90MM (up 123.54%) and basic earnings per
share -$1.96 vs -$0.47. Envision Healthcare is expected to report earnings on May 1st, 2018. The report will be for the fiscal
period ending March 31st, 2018. The reported EPS for the same quarter last year was $0.69. The estimated EPS forecast for the next
fiscal year is $3.82 and is expected to report on February 26th, 2019.
To read the full Envision Healthcare Corporation (EVHC) report, download it here: http://Fundamental-Markets.com/register/?so=EVHC
-----------------------------------------
TAYLOR MORRISON HOME CORPORATION (TMHC) REPORT OVERVIEW
Taylor Morrison Home's Recent Financial Performance
For the three months ended December 31st, 2017 vs December 31st, 2016, Taylor Morrison Home reported revenue of
$1,299.68MM vs $1,196.97MM (up 8.58%) and basic earnings per share $0.26 vs $0.62 (down 58.06%). For the twelve months ended
December 31st, 2017 vs December 31st, 2016, Taylor Morrison Home reported revenue of $3,885.29MM vs $3,550.03MM (up 9.44%) and
basic earnings per share $1.47 vs $1.69 (down 13.02%). Taylor Morrison Home is expected to report earnings on April 26th, 2018. The
report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $0.30. The
estimated EPS forecast for the next fiscal year is $3.00 and is expected to report on February 6th, 2019.
To read the full Taylor Morrison Home Corporation (TMHC) report, download it here: http://Fundamental-Markets.com/register/?so=TMHC
-----------------------------------------
VERTEX PHARMACEUTICALS INCORPORATED (VRTX) REPORT OVERVIEW
Vertex Pharmaceuticals' Recent Financial Performance
For the three months ended December 31st, 2017 vs December 31st, 2016, Vertex Pharmaceuticals reported revenue
of $651.63MM vs $458.71MM (up 42.06%) and basic earnings per share $0.39 vs $0.13 (up 200.00%). For the twelve months ended
December 31st, 2017 vs December 31st, 2016, Vertex Pharmaceuticals reported revenue of $2,488.65MM vs $1,702.18MM (up 46.20%) and
basic earnings per share $1.06 vs -$0.46. Vertex Pharmaceuticals is expected to report earnings on April 26th, 2018. The report
will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was $0.13.
To read the full Vertex Pharmaceuticals Incorporated (VRTX) report, download it here: http://Fundamental-Markets.com/register/?so=VRTX
-----------------------------------------
RESHAPE LIFESCIENCES INC. (RSLS) REPORT OVERVIEW
ReShape Lifesciences Inc.'s Recent Financial Performance
For the three months ended September 30th, 2017 vs September 30th, 2016, ReShape Lifesciences Inc. reported
revenue of $0.36MM vs $0.30MM (up 21.29%) and basic earnings per share -$1.06 vs -$11.77. For the twelve months ended December
31st, 2016 vs December 31st, 2015, ReShape Lifesciences Inc. reported revenue of $0.79MM vs $0.29MM (up 169.42%) and basic
earnings per share -$37.53 vs -$298.97. ReShape Lifesciences Inc. is expected to report earnings on March 6th, 2018. The
report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was -$2.65. The
estimated EPS forecast for the next fiscal year is -$0.69 and is expected to report on March 6th, 2018.
To read the full ReShape Lifesciences Inc.(RSLS) report, download it here: http://Fundamental-Markets.com/register/?so=RSLS
-----------------------------------------
AMERICAN AXLE & MANUFACTURING HOLDINGS, INC. (AXL) REPORT OVERVIEW
American Axle & Manufacturing's Recent Financial Performance
For the three months ended December 31st, 2017 vs December 31st, 2016, American Axle & Manufacturing reported
revenue of $1,733.90MM vs $946.50MM (up 83.19%) and basic earnings per share $0.87 vs $0.60 (up 45.00%). For the twelve months
ended December 31st, 2017 vs December 31st, 2016, American Axle & Manufacturing reported revenue of $6,266.00MM vs $3,948.00MM (up
58.71%) and basic earnings per share $3.22 vs $3.08 (up 4.55%). American Axle & Manufacturing is expected to report earnings on May
4th, 2018. The report will be for the fiscal period ending March 31st, 2018. The reported EPS for the same quarter last year was
$1.03. The estimated EPS forecast for the next fiscal year is $3.47 and is expected to report on February 15th, 2019.
To read the full American Axle & Manufacturing Holdings, Inc. (AXL) report, download it here: http://Fundamental-Markets.com/register/?so=AXL
-----------------------------------------
LATTICE SEMICONDUCTOR CORPORATION (LSCC) REPORT OVERVIEW
Lattice Semiconductor's Recent Financial Performance
For the three months ended September 30th, 2017 vs September 30th, 2016, Lattice Semiconductor reported revenue
of $91.97MM vs $113.23MM (down 18.77%) and basic earnings per share -$0.35 vs -$0.10. For the twelve months ended December 31st,
2016 vs December 31st, 2015, Lattice Semiconductor reported revenue of $427.05MM vs $405.97MM (up 5.19%) and basic earnings per
share -$0.45 vs -$1.36. Lattice Semiconductor is expected to report earnings on May 8th, 2018. The report will be for the fiscal
period ending March 31st, 2018. The reported EPS for the same quarter last year was $0.03. The estimated EPS forecast for the next
fiscal year is $0.38 and is expected to report on February 12th, 2019.
To read the full Lattice Semiconductor Corporation (LSCC) report, download it here: http://Fundamental-Markets.com/register/?so=LSCC
-----------------------------------------
ABOUT FUNDAMENTAL MARKETS
Fundamental Markets serves thousands of members and have provided research through some of the world's leading
brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals
worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA®
BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst®
(CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.
REGISTERED MEMBER STATUS
Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers
("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes
qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers.
Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit
firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries
regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail
at compliance@Fundamental-Markets.com.
LEGAL NOTICES
Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental
Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result
from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the
material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the
publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm,
investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full
disclaimer, disclosure, and terms of service please visit our website.
Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: media@Fundamental-Markets.com
© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network
manager at partnership@Fundamental-Markets.com.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority,
Inc.
